Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto
Herantis Pharma Plc Company release 9 June 2023 at EEST Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Antti Vuolanto Position: Chief Executive Officer Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 33224/5/8 ____________________________________________ Transaction date: 2023-06-09 Outside a trading venue Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Name